Clerc Pascal, Coll Constans Maria Gràcia, Lulka Hubert, Broussaud Stéphanie, Guigné Charlotte, Leung-Theung-Long Stéphane, Perrin Christophe, Knauf Claude, Carpéné Christian, Pénicaud Luc, Seva Catherine, Burcelin Rémy, Valet Philippe, Fourmy Daniel, Dufresne Marlène
Institut National de la Santé et de la Recherche Médicale Unit 531, Institut Fédératif de Recherche 31, Université de Toulouse 3, 31432 Toulouse Cedex 4, France.
Endocrinology. 2007 Mar;148(3):1039-49. doi: 10.1210/en.2006-1064. Epub 2006 Nov 22.
The role of cholecystokinin (CCK) as a satiety factor has been extensively documented. Although most work implies that CCK1 receptor mediates the control of food intake, a contributing role for CCK2 receptor (CCK2R) in the CCK-induced satiety cannot be totally excluded. The hypothesis that CCK2R invalidation disrupts regulatory pathways with impact on feeding behavior was examined in CCK2R(-/-) mice. CCK2R(-/-) mice developed obesity that was associated with hyperphagia. Obesity was related with increased fat deposition resulting from adipocyte hypertrophy. Expression of several adipokines was dysregulated consistently with obesity. Moreover, obesity was associated with disturbed glucose homeostasis as revealed by increased fasting glycemia and insulinemia, impaired glucose tolerance, and hepatic insulin resistance in CCK2R(-/-) mice. In vitro analysis of isolated adipocytes metabolism was consistent with increased storage but preserved insulin sensitivity. Suppression of feeding and concomitant increased expression of hypothalamic proopiomelanocortin after intracerebroventricular injection of gastrin into control mice demonstrates that hypothalamic CCK2 receptors mediate inhibition of food intake. Comparative analysis of hypothalamic mediator gene expression in fed knockout and control mice demonstrated overexpression of ghrelin receptors in CCK2R(-/-) mice, indicating up-regulation of orexigenic pathways. This effect was also observed after body weight normalization, indicating a causative role in the development of hyperphagia and obesity of CCK2R(-/-) mice. Our results give evidence that CCK2 receptor activity plays a contributing regulatory role in the control of food intake.
胆囊收缩素(CCK)作为一种饱腹感因子的作用已得到广泛记载。尽管大多数研究表明CCK1受体介导对食物摄入的控制,但CCK2受体(CCK2R)在CCK诱导的饱腹感中所起的作用也不能完全排除。我们在CCK2R基因敲除(CCK2R(-/-))小鼠中研究了CCK2R缺失破坏调节通路并影响摄食行为这一假说。CCK2R(-/-)小鼠出现肥胖,且伴有摄食过量。肥胖与脂肪细胞肥大导致的脂肪沉积增加有关。几种脂肪因子的表达与肥胖一致失调。此外,如CCK2R(-/-)小鼠空腹血糖和胰岛素水平升高、糖耐量受损及肝脏胰岛素抵抗所显示,肥胖与葡萄糖稳态紊乱有关。对分离的脂肪细胞代谢进行的体外分析表明其储存增加但胰岛素敏感性保持不变。向对照小鼠脑室内注射胃泌素后摄食受到抑制,同时下丘脑促阿片黑素皮质素的表达增加,这表明下丘脑CCK2受体介导对食物摄入的抑制。对喂食后的基因敲除小鼠和对照小鼠下丘脑介质基因表达的比较分析表明,CCK2R(-/-)小鼠中胃饥饿素受体过表达,提示食欲亢进通路上调。在体重恢复正常后也观察到了这种效应,表明其在CCK2R(-/-)小鼠食欲亢进和肥胖的发生中起因果作用。我们的结果证明CCK2受体活性在食物摄入控制中起辅助调节作用。